Cequr SA
Explore this company’s associated devices, FDA decisions and regulatory history.

Cequr SA
- Regulatory records
- 1
- Linked recall entries
- 0
- Headquarters
- Not reported
- Brand website
- Not reported
What the linked records show
MedtechLedger currently links 1 FDA record to the applicant name Cequr SA. The collection includes 1 510(k) clearance. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Apr 10, 2026 to Apr 10, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code OPP appears in 1 of the 1 linked filings. The collection spans 1 FDA product code. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
Applicant mailing address recorded by FDA: Ebenaustrasse 10, Horw Luzern, 6048, CH. Recorded on K252757, decision dated Apr 10, 2026.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Regulatory record history
CeQur Simplicity On-Demand Insulin Delivery System
K252757 · 510(k) clearance
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.